Short Description Intellia Therapeutics develops in vivo crispr therapeutics to support healthy longevity.
Description Intellia Therapeutics is a biotechnology innovator targeting the fundamental mechanisms of aging through in vivo crispr therapeutics. The company leverages advancements in gene editing and collaborates with leading institutions to translate cutting‑edge science into practical interventions. By focusing on science‑backed solutions, Intellia Therapeutics aims to extend healthspan and improve quality of life across the globe.
Address 40 Erie St, Cambridge, MA, USA